News
On Sunday June 9th, 2013 the Society of Nuclear Medicine and Molecular Imaging will be holding a patient education day at their annual meeting. The patient program is designed for patient and those who support them as well as the general public to learn more about molecular imaging and treatments. There will be a special NETs breakout in the afternoon covering specific imaging and treatments available for those with NETS delivered by international experts. Click here to download the full brochure, registration is free and includes lunch. The conference will be at the Vancouver Convention Center.
Dr. Emily K. Bergsland NETs Oncologist at UCSF's Helen Diller Comprehensive Cancer Center published an overveiw of Neuroendocrine Tumors "The Evolving Landscape of Neuroendocrine Tumors" in the Seminars in oncology Journal 1 February 2013. (volume 40 issue 1 Pages 4-22 DOI: 10.1053/j.seminoncol.2012.11.013)
Josh Mailman, NorCal CarciNET's President will be traveling to India and Singapore at the end of February to speak at the 2nd World Congress of Ga68 and PRRNT in India and the 22nd Annual Singapore Radiological Society Meeting in Singapore. Josh, who was recently elected to chair the Patient Advocacy Advisory Board for the Society of Nuclear Medicine and Molecular Imaging will be speaking on the role of patient support groups for those with NETs and patient education for those looking seeking Ga68 and PRRNT. Josh co-manages a separate site PRRTInfo.org for those wishing to learn more about PRRNT.
Patient knowledge and understanding of radiation from diagnostic imaging is lacking, according to a research letter published online Dec. 31, 2012, in JAMA Internal Medicine . More than half of patients surveyed heard nothing in the media about radiation from medical imaging, and many of those aware of radiation exposure substantially underestimated dose.
Read more at healthimaging.com
We at NorCal CarciNET are working with the Society of Nuclear Medicine and Molecular Imaging to provide information for patients on the benifits and risks of nuclear diagnostic and treatment. To learn more about molecular imaging please see discovermi.org.